Midlife physical activity was inversely associated with plasma NfL and GFAP at age 67, suggesting that midlife PA may reduce risk for neurodegeneration in older age via amyloid-independent mechanisms.
Key Findings
Results
Physical activity at age 56 was inversely associated with neurofilament light chain (NfL) levels at age 67.
Sample: 564 men from the Vietnam Era Twin Study of Aging
B = -0.10, 95% CI: -0.17 to -0.03
Generalized estimating equations were used for analysis
PA was measured as metabolic equivalent of energy expenditure (MET) hours during the preceding week
Results
Physical activity at age 56 was inversely associated with glial fibrillary acidic protein (GFAP) levels at age 67.
B = -0.08, 95% CI: -0.15 to -0.01
Sample: 564 men assessed at ages 56 and 67
GFAP was measured as a plasma AD-related biomarker at age 67
Association was statistically significant based on confidence intervals not crossing zero
Results
Physical activity at age 56 was not significantly associated with phosphorylated tau 217 (p-tau217) or the amyloid beta 42/40 ratio at age 67.
Plasma p-tau217 and Aβ42/40 ratio were assayed at age 67
No significant associations were found for these amyloid-related biomarkers
This null finding for amyloid biomarkers contrasts with the significant findings for NfL and GFAP
Suggests the mechanism linking midlife PA to later neurodegeneration may be amyloid-independent
Results
Physical activity at age 67 was not reported as significantly associated with any of the AD-related biomarkers at age 67.
PA was assessed at both ages 56 and 67 using MET hours from the preceding week
The significant inverse associations with NfL and GFAP were specific to age 56 PA, not age 67 PA
This pattern suggests a prospective, midlife-specific effect of PA on later neurodegeneration markers
Methods
The study population consisted entirely of male twins from the Vietnam Era Twin Study of Aging, assessed prospectively across approximately one decade.
N = 564 men
PA reported at ages 56 and 67; biomarkers measured at age 67
Physical activity was self-reported as MET hours during the preceding week at each time point
Four plasma AD-related biomarkers were assayed: p-tau217, NfL, Aβ42/40 ratio, and GFAP
What This Means
This research suggests that being physically active in midlife (around age 56) is linked to lower levels of certain brain damage markers in blood about a decade later (around age 67). Specifically, men who were more physically active at age 56 had lower levels of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) — two proteins that signal nerve cell damage and brain cell stress — when measured at age 67. However, physical activity was not linked to markers more directly related to amyloid plaques, which are a hallmark of Alzheimer's disease.
This distinction is important because it suggests that the brain-protective effects of midlife exercise may work through pathways that are separate from the amyloid buildup traditionally associated with Alzheimer's disease. In other words, staying active in middle age might help protect the brain through mechanisms involving general neurodegeneration and inflammation rather than by preventing amyloid accumulation specifically. Physical activity measured closer to age 67 did not show the same associations, hinting that the timing of exercise — particularly during midlife — may matter.
The study followed 564 male twins over roughly a decade, which provides stronger evidence of a time-ordered relationship between exercise and brain health than studies that only measure both at one point in time. However, because the sample was exclusively men who served in the military during the Vietnam era, it is unclear whether these findings would apply equally to women or more diverse populations.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Iso-Markku P, Tu X, Rissman R, Gillespie N, Elman J, Fennema-Notestine C, et al.. (2026). Prospective study on physical activity and Alzheimer's disease-related biomarkers.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71755